retatrutide clinical trial duration Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide UK: 2026 Clinical Trial

2 Hims & Hers has been one of the most prominent players in the direct-to-consumer GLP-1 space, yet the company has faced its own headwinds in recent months after being required to pull access to compounded semaglutide following FDA action against mass compounding of GLP-1 drugs

Stay Informed Key dates to watch in 2026: TRIUMPH-1 and TRIUMPH-2 results (mid-2026), head-to-head retatrutide vs tirzepatide results (December 2026), and any NDA filing announcements from Eli Lilly

Jellys favorite Waffle House item is the hash brown bowl: double hash browns, American cheese, scrambled eggs, sausage patties, and onions, peppers, and tomatoes

Gastroenterology, 165 (5), 12061218

Biochem Pharmacol 229:116471 [DOI] [PubMed] [Google Scholar] Kelly CA, Sipos JA (2024) Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists

For instance, Wegovy (specifically approved for weight management) has demonstrated impressive results in clinical trials, with many patients losing substantial percentages of their body weight